nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB3—brown adipose tissue—adrenal gland cancer	0.6	0.947	CbGeAlD
Bupranolol—ADRB1—cardiac atrium—adrenal gland cancer	0.034	0.0537	CbGeAlD
Bupranolol—Timolol—ABCB1—adrenal gland cancer	0.023	0.557	CrCbGaD
Bupranolol—Nadolol—ABCB1—adrenal gland cancer	0.0183	0.443	CrCbGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0158	0.0485	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 signaling events—TSHR—adrenal gland cancer	0.0156	0.0479	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0136	0.0418	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 trafficking events—TSHR—adrenal gland cancer	0.0123	0.0379	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00975	0.03	CbGpPWpGaD
Bupranolol—ADRB1—Endothelin Pathways—GNAS—adrenal gland cancer	0.00971	0.0299	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00936	0.0288	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00915	0.0282	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00871	0.0268	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00663	0.0204	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00604	0.0186	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00579	0.0178	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00567	0.0175	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00566	0.0174	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00522	0.0161	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00517	0.0159	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00505	0.0156	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.0049	0.0151	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00465	0.0143	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00397	0.0122	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00393	0.0121	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00385	0.0118	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00382	0.0118	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00375	0.0115	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00359	0.011	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00354	0.0109	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00351	0.0108	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 signaling events—EGFR—adrenal gland cancer	0.00345	0.0106	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	0.00344	0.0106	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0034	0.0105	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00337	0.0104	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00329	0.0101	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0031	0.00953	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00303	0.00932	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00291	0.00894	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00284	0.00875	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00276	0.00849	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0027	0.00831	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00236	0.00725	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00231	0.0071	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00227	0.00698	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00224	0.00691	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00222	0.00684	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00222	0.00682	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00218	0.00669	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0021	0.00647	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00206	0.00634	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00206	0.00633	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00204	0.00627	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00202	0.00621	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00201	0.00619	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.002	0.00616	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00198	0.00608	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00187	0.00575	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00182	0.0056	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00182	0.00559	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00176	0.00541	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—POMC—adrenal gland cancer	0.00139	0.00427	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00133	0.0041	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0013	0.00401	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0013	0.00401	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00122	0.00376	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00122	0.00375	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00121	0.00372	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GNRH1—adrenal gland cancer	0.0012	0.00371	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—GNAS—adrenal gland cancer	0.0012	0.00368	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00119	0.00367	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00119	0.00365	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00118	0.00364	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00117	0.00359	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00116	0.00358	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00116	0.00357	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00111	0.00341	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00111	0.0034	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SPRY2—adrenal gland cancer	0.0011	0.00339	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00108	0.00334	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00108	0.00333	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00108	0.00332	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TSHR—adrenal gland cancer	0.00107	0.0033	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00106	0.00325	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00106	0.00325	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00105	0.00325	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00104	0.00321	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00102	0.00314	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MEN1—adrenal gland cancer	0.00101	0.00311	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	0.000823	0.00253	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	0.000805	0.00248	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000783	0.00241	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000774	0.00238	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00077	0.00237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000757	0.00233	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000723	0.00222	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000715	0.0022	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—POMC—adrenal gland cancer	0.000711	0.00219	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000707	0.00218	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000699	0.00215	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000691	0.00213	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000676	0.00208	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000656	0.00202	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000654	0.00201	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDC42—adrenal gland cancer	0.000653	0.00201	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000642	0.00198	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000639	0.00197	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	0.000637	0.00196	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF2—adrenal gland cancer	0.00063	0.00194	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000627	0.00193	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GNAS—adrenal gland cancer	0.000624	0.00192	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	0.000623	0.00192	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000614	0.00189	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000609	0.00187	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	0.000599	0.00184	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	0.000586	0.0018	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TERT—adrenal gland cancer	0.000524	0.00161	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000465	0.00143	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000457	0.00141	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BAD—adrenal gland cancer	0.000456	0.0014	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000455	0.0014	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000447	0.00138	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	0.000422	0.0013	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—adrenal gland cancer	0.00042	0.00129	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BRAF—adrenal gland cancer	0.000415	0.00128	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	0.000413	0.00127	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000402	0.00124	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.000388	0.00119	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	0.000379	0.00117	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000374	0.00115	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000371	0.00114	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	0.000366	0.00113	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	0.000362	0.00112	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000361	0.00111	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000353	0.00109	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	0.000311	0.000957	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	0.000304	0.000936	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.0003	0.000923	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	0.000271	0.000833	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	0.000265	0.000815	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	0.000249	0.000768	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	0.000246	0.000758	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	0.000244	0.000751	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	0.000241	0.000742	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000239	0.000735	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGFR—adrenal gland cancer	0.000238	0.000731	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000234	0.000719	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TP53—adrenal gland cancer	0.0002	0.000614	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000178	0.000548	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000174	0.000536	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	0.000141	0.000434	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	0.000138	0.000425	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	0.000118	0.000364	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	0.000116	0.000357	CbGpPWpGaD
